High-resolution mass spectrometry for analyzing small molecules and biomolecules
Official title: Select Series Cyclic IMS Mass Spectrometry System
Funded at University of Colorado · NIH-11108710 · Data updated 2026-11-12
This study is all about getting a new, advanced machine to help scientists at the University of Colorado Boulder and other places in Colorado better analyze tiny molecules and proteins, which could eventually lead to better treatments and personalized medicine for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado NIH-funded |
| Lab location | 1 site (Boulder, UNITED STATES) |
| Project start | May 1, 2025 |
| Project end | April 30, 2026 |
| Funding year | 2025 |
| Award (this year) | $1,089,778 |
| NIH project number | 1S10OD038278-01 |
| Project ID | NIH-11108710 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals with conditions that require precise biomolecular analysis, such as those undergoing treatment for complex diseases.
✕Less likely to help
Patients with conditions that do not involve biomolecular analysis or those outside the age range of 15 years may not receive direct benefits from this research.
What this research studies
This research aims to acquire a state-of-the-art mass spectrometry system to enhance the analysis of small molecules and biomolecules at the University of Colorado Boulder and other institutions in Colorado. The new system will replace an outdated instrument and will support various applications, including the measurement of biomolecule masses, analysis of protein structures, and mapping of chemical modifications. Patients may benefit indirectly through improved research capabilities that could lead to advancements in drug development and personalized medicine.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and efficient methods for analyzing biomolecules, potentially improving drug development and treatment options for patients.
How similar studies have gone: Previous research has shown success with advanced mass spectrometry techniques, indicating that this approach is likely to yield valuable insights and improvements in biomolecular analysis.
Where this research is happening
-
University of Colorado
Boulder, United States Active
Researchers
- Principal investigator: Ahn, Natalie G. — University of Colorado
- Study coordinator: Ahn, Natalie G.
Related research
Other NIH-funded projects on the same topics.
-
Empowering youth to prevent violence in Denver communities
A community-led program in Denver is testing new ways to reduce youth violence by engaging youth, families, and local partners, and by measuring how well these strategies work.
-
Center that enables faster, better population science research at CU Boulder
A PI-led center at the University of Colorado aims to sustain and expand population science research by supporting researchers and infrastructure for five more years.
-
AI-powered system to improve teamwork in cardiac surgery
A research project is testing an AI-driven system that listens to team conversations during heart surgeries to spot teamwork patterns and give real-time feedback to improve patient safety.
-
Hemp-derived CBD for reducing cannabis use in high-THC concentrate users
A randomized, placebo-controlled trial tests whether hemp-derived CBD can help adults who mainly use high-potency cannabis concentrates reduce their cannabis use.
-
Gene-environment factors shaping Alzheimer's risk across life (twin study)
This project studies how modifiable lifestyle and environmental factors, viewed through twin data, influence the risk of Alzheimer’s disease and related dementias across different stages of life.
-
CU Boulder Cryo-ET Center: making advanced cellular imaging accessible
A new satellite center at the University of Colorado Boulder will provide cryo-electron tomography services and training to researchers studying cells, organelles, and large molecular machines.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.